Valuation: Camlin Fine Sciences Limited

Market Cap 16.15B 170M 152M 140M 127M 237M 242M 1.67B 671M 8.49B 638M 625M 26.78B P/E 2027 *
21x
P/E 2028 * 10.4x
Enterprise Value 16.15B 170M 152M 140M 127M 237M 242M 1.67B 671M 8.49B 638M 625M 26.78B EV / Sales 2027 *
0.76x
EV / Sales 2028 * 0.66x
Free-Float
55.67%
Yield 2027 *
-
Yield 2028 * -
1 day+2.06%
1 week+4.59%
Current month-9.67%
1 month-9.67%
3 months-33.11%
6 months-33.80%
Current year-43.34%
1 week 79.01
Extreme 79.01
85.95
1 month 79
Extreme 79
98
Current year 79
Extreme 79
192
1 year 79
Extreme 79
202.55
3 years 79
Extreme 79
334.7
5 years 79
Extreme 79
334.7
10 years 33.4
Extreme 33.4
334.7
Manager TitleAgeSince
Chief Executive Officer 63 -
Chief Executive Officer 60 01/06/2021
Director of Finance/CFO - 18/08/2026
Director TitleAgeSince
Director/Board Member 60 04/08/2014
Chairman 63 17/06/2021
Director/Board Member 60 13/10/2017
Date Insider Type Main position Quantity % Market Cap. Importance
9/9/24
Infinity Holdings
SellCompany 1,338,600 0.7992%
9/9/24
Infinity Holdings
SellCompany 663,586 0.3962%
Change 5-day change 1-year change 3-year change Capi.($)
+2.06%+4.59%-57.17%-43.34% 170M
+0.70%+5.01%+17.85%+90.37% 84.98B
+1.46%-0.50%+19.49%+32.97% 44.52B
+0.42%-0.61%+14.00%-16.35% 34.88B
+1.86%+1.83%+13.13%+18.20% 34.16B
-0.71%-4.05%+18.13%+47.75% 32.15B
+0.75%+3.33%-1.71%+29.41% 26.59B
-0.12%-3.77%+52.03%+38.08% 23.93B
-0.38%+2.56%-42.70%-35.95% 18.91B
-3.05%-4.36%+13.31%+12.15% 15.61B
Average +0.30%+0.40%+4.64%+17.33% 31.59B
Weighted average by Cap. +0.45%+0.93%+14.23%+37.76%

Financials

2027 *2028 *
Net sales 21.33B 225M 201M 185M 168M 313M 319M 2.21B 886M 11.22B 843M 825M 35.39B 24.35B 256M 230M 211M 191M 358M 365M 2.52B 1.01B 12.81B 962M 942M 40.4B
Net income 765M 8.06M 7.22M 6.64M 6.01M 11.24M 11.45M 79.15M 31.77M 402M 30.24M 29.59M 1.27B 1.56B 16.38M 14.67M 13.49M 12.22M 22.85M 23.28M 161M 64.59M 818M 61.46M 60.15M 2.58B
Net Debt - -
Projected Income Statement - Annual - Camlin Fine Sciences Limited
Logo Camlin Fine Sciences Limited
Camlin Fine Sciences Limited is an India-based specialty chemicals company, which is engaged in the research, development, manufacturing and marketing of specialty chemicals, ingredients, and additive blends. The Company's products portfolio is categorized into shelf-life solutions, performance chemicals, aroma ingredients, and health and wellness. Its products include catechol, tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), Ascorbyl Palmitate (ASP), 4-Tertiary Butyl Catechol, Xtendra, Guaiacol, Para DiMethoxy Benzene, NaSure, Hydroquinone, and Veratrole. Its aroma ingredients mainly include Vanillin, Ethyl Vanillin, and Natural Vanillin. The Company's products are used in varied industries, such as human food, animal feed, pet food, agrochemicals, petrochemicals, pharmaceuticals, nutraceuticals, flavors and fragrances, and health care. Its brands include Ezential, Nasure, adorr, Dinamics, Xtendra, and Biosus.
Employees
674
Date Price Change Volume
30/10/26 INR 84.05 +2.06% 151,426
29/10/26 INR 82.35 -1.96% 22,594
28/10/26 INR 84.00 +0.17% 50,404
27/10/26 INR 83.86 +0.60% 14,858
26/10/26 INR 83.36 +3.73% 96,858
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Camlin Fine Sciences Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
84.05INR
Average target price
152.50INR
Spread / Average Target
+81.44%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Camlin Fine Sciences Limited
  1. Stock Market
  2. Stocks
  3. CAMLINFINE Stock